Newsquawk Logo

CVS Health Corporation (CVS) Q4 2025 (USD): EPS 1.09 (exp. 1.00), Revenue 105.7bln (exp. 103.67bln)

CVS Health's Q4 earnings report beat expectations on both EPS and revenue, indicating a solid performance despite a year-over-year drop in adjusted EPS driven by the Medicare Part D adjustments related to the Inflation Reduction Act.

Newsquawk StaffPublished On the live feed at — 5 more headlines followed before this page went public
Newsquawk headlinesUTC

Quest Diagnostics Incorporated (DGX) Q4 2025 (USD): EPS 2.42 (exp. 2.36), Revenue 2.81bln (exp. 2.75bln), Next FY EPS 10.50-10.70 (exp. 10.42), Next FY Rev. 11.7-11.82bln (exp. 11.38bln)

Ferrari (RACE IM) Q4 (EUR) EPS 2.14 (exp. 2.05), Revenue 1.80bln (exp. 1.7bln); guides initial FY26 EPS "more than" 9.45 (exp. 9.55), Revenue approx. 7.50bln (exp. 7.53bln)

CVS Health Corporation (CVS) Q4 2025 (USD): EPS 1.09 (exp. 1.00), Revenue 105.7bln (exp. 103.67bln)

The PBoC will continue implementing appropriately loose monetary policy

Taiwanese trade negotiators have departed for the US to hold final discussions on trade deal

Open the platform and use it. The whole workspace is free to try, with no signup and no card. When you want the headlines arriving live instead of on a delay, Newsquawk Pro is £24.99 for 7 days.

Try the platform free
Free. No signup, no card.
  • Adj. EPS of 1.09 decreased from 1.19 Y/Y, primarily due to a decline in adj. operating income in the Health Care Benefits segment, reflecting changes in the seasonality of the Medicare Part D programme due to the impact of the Inflation Reduction Act.
  • Q4 MBR 94.8%, remained consistent with the prior year, as improved underlying performance in the Government business was offset by changes in the seasonality of the Medicare Part D programme
  • MBR decreased to 91.2% in FY (vs 92.5% Y/Y), primarily driven by improved underlying performance in the Government business and higher favourable prior year development.
  • Medical membership 26.6mln (decreased 112,000 members vs Q3) reflecting declines in the individual exchange product line, partially offset by an increase in Commercial ASC membership.
  • FY medical membership decreased 504,000 Y/Y reflecting declines in the individual exchange and Government product lines, partially offset by an increase in Commercial ASC membership.

GUIDANCE:

  • FY EPS view 7.00-7.20 (exp. 7.18)
Context

While the short-term metrics, such as medical membership, show some decline, the FY guidance suggests stability, as the outlook aligns closely with market expectations. Investors will likely focus on how these headwinds in the health benefits segment play into broader trends and potential implications for future earnings growth.

External

Related headlines

The whole workspace, free to try.

Try it free
Newsquawk Logo

© 2026 Newsquawk. All rights reserved.